<DOC>
	<DOCNO>NCT02658851</DOCNO>
	<brief_summary>This study protocol evaluate efficacy Bovie Medical 's J-Plasma® helium base plasma technology reduction lymphoceles follow pelvic lymph node dissection ( PLND ) robotic assist radical prostatectomy ( RARP ) . The J-Plasma® handpiece use PLND dissect lymph node seal lymphatic channel prevent lymph leakage .</brief_summary>
	<brief_title>Cold Plasma Reduction Lymphoceles Following PLND</brief_title>
	<detailed_description>Participants evaluate scheduled PLND Robotic Assisted Radical Prostatectomy meet study inclusion criterion also give informed consent enrol . Enrolled participant PLND perform use J-Plasma® dissection seal lymphatic channel . An abdominal-pelvic ultrasound complete follow-up period range 4-12 week post operatively determine lymphocele present . The occurrence rate lymphoceles trial group compare retrospective data principal investigator 's practice publish data determine occurrence rate reduce .</detailed_description>
	<mesh_term>Lymphocele</mesh_term>
	<criteria>1 . Primary diagnosis Prostate Cancer ( ICD10 : C61 ) 2 . Prostate Specific Antigen ( PSA ) level =/ &gt; 10ng/mL 3 . Gleason score =/ &gt; 7 4 . Planned Elective Robotic Assisted Radical Prostatectomy plan pelvic lymph node dissection . 5 . Willing able return clinic standard care abdominal ultrasound within 12 week post operatively . 6 . Able provide inform consent Must answer : 1 . Patient unwilling unable sign understand inform consent 2 . Patient reside outside United States 3 . Performance Lymph node dissection abort .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>lymphocele</keyword>
	<keyword>pelvic lymph node dissection</keyword>
	<keyword>robotic assist radical prostatectomy</keyword>
	<keyword>PLND</keyword>
	<keyword>RARP</keyword>
	<keyword>prostatectomy</keyword>
	<keyword>Patel</keyword>
</DOC>